| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/14/2004 | EP1436290A1 Alkyne-aryl-naphthyridin-4(1h)-0ne derivatives as type iv phosphodiesterase inhibitor |
| 07/14/2004 | EP1436287A2 Small organic molecule regulators of cell proliferation |
| 07/14/2004 | EP1436272A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 07/14/2004 | EP1436269A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1436252A1 Hydroxyfattysulfonic acid analogs |
| 07/14/2004 | EP1436008A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 07/14/2004 | EP1436007A2 Compounds for use as surfactants |
| 07/14/2004 | EP1435994A2 Novel use of pulmonary surfactant |
| 07/14/2004 | EP1435986A2 Igf-binding protein-derived peptide or small molecule |
| 07/14/2004 | EP1435957A2 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes |
| 07/14/2004 | EP1435952A1 8-amino- 1,2,4]triazolo 1,5-a]pyridine-6-carboxylic acid amide |
| 07/14/2004 | EP1435950A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435949A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435948A1 Aminoisoxazole derivatives active as kinase inhibitors |
| 07/14/2004 | EP1435946A2 Linked biaryl compounds |
| 07/14/2004 | EP1435942A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435935A2 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 07/14/2004 | EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435933A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435925A2 Gap junctions and edhf |
| 07/14/2004 | EP1435924A2 Therapeutic composition and use |
| 07/14/2004 | EP1435894A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 07/14/2004 | EP1435826A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 07/14/2004 | EP1365760A4 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 07/14/2004 | EP1315793A4 Methods for culturing human lung mast cells and uses thereof |
| 07/14/2004 | EP1248630B1 Use of a dermatological composition containing oligosaccharides for the treatment of skin diseases |
| 07/14/2004 | EP1235803B1 Urea compounds having muscarinic receptor antagonist activity |
| 07/14/2004 | EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 07/14/2004 | EP1224179B1 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/14/2004 | EP1210350B1 Water soluble sdz-rad esters |
| 07/14/2004 | EP1037887B1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability |
| 07/14/2004 | EP0961775B1 Purine l-nucleosides, analogs and uses thereof |
| 07/14/2004 | CN1512993A Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases |
| 07/14/2004 | CN1512992A Novel adenine derivatives |
| 07/14/2004 | CN1512985A Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 07/14/2004 | CN1512888A Modified proteins, designer toxins and methosd of making thereof |
| 07/14/2004 | CN1512875A Inhalation capsules |
| 07/14/2004 | CN1511830A Compound used as antiphlogistic |
| 07/14/2004 | CN1511575A Medicinal composition for preventing and curing dyspneic cough and pulmonary emphysema and its preparing method |
| 07/14/2004 | CN1511568A Method for producing bagged tea for removing intense heat from throat |
| 07/14/2004 | CN1511564A Method for producing Biyuanqing oral liquid |
| 07/14/2004 | CN1511551A Medicinal composition for treating and preventing nasal sinusitis and preparing method |
| 07/14/2004 | CN1511550A Medicinal preparation for reducing nicotine and use |
| 07/14/2004 | CN1511543A Fast curnig powder for inflammation and swelling |
| 07/14/2004 | CN1511519A Therapy for immunological disease of type 2 T auxiliary cell mediated |
| 07/14/2004 | CN1157403C Method for separating active part of caterpillar fungus, and medical use thereof |
| 07/14/2004 | CN1157392C 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors |
| 07/14/2004 | CN1157380C Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants agents |
| 07/14/2004 | CN1157378C Qunoline derivatives |
| 07/14/2004 | CN1157371C Monohydrate of cis-4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl] cyclohexancecarboxylate |
| 07/14/2004 | CN1157224C Novel amide derives. as growth hormone secretagogues |
| 07/14/2004 | CN1157221C Health compsn. |
| 07/14/2004 | CN1157206C Asthma-treating medicine liquid |
| 07/14/2004 | CN1157200C Syrup and granules for treating laryngopharyngitis and preparation process thereof |
| 07/13/2004 | US6762200 Phospholipase inhibitors |
| 07/13/2004 | US6762199 Ability to modulate the interaction of the ligand vcam-1 with its integrin receptor alpha 4 beta 1; treatment of inflammation, atherosclerosis, autoimmune disease |
| 07/13/2004 | US6762196 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 07/13/2004 | US6762195 Treating diseases mediated by tumor necrosis factor; inhibit angiogenesis and treatment of cancer, inflammatory, and autoimmune diseases |
| 07/13/2004 | US6762186 Use to treat allergy, nasal congestion, inflammatory and central nervous system-related diseases |
| 07/13/2004 | US6762175 Fatty acid derivatives |
| 07/13/2004 | US6762170 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 07/13/2004 | US6762165 Snail venom; muscular disorders, central nervous system disorders, cardiovascular disorders |
| 07/13/2004 | US6761894 Immune response against intracellular pathogens and in particular mycobacterium tuberculosis. |
| 07/13/2004 | CA2301267C Method of enhancing bioavailability of fexofenadine and its derivatives |
| 07/13/2004 | CA2268684C Process for alkylating hindered sulfonamides |
| 07/13/2004 | CA2259270C Pharmaceutical preparation containing nimesulide for oral administration |
| 07/13/2004 | CA2118859C Enantiomers of 1-[(4-chlorophenyl)-phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine |
| 07/08/2004 | WO2004056866A1 Asthma susceptibility locus |
| 07/08/2004 | WO2004056810A1 Xanthine derivatives as muscarinic receptor antagonists |
| 07/08/2004 | WO2004056809A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/08/2004 | WO2004056808A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/08/2004 | WO2004056800A1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056773A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/08/2004 | WO2004056767A1 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists |
| 07/08/2004 | WO2004056376A1 Pharmaceutical formulations containing nitrate |
| 07/08/2004 | WO2004056310A2 Methods of diagnosis and treatment of interstitial lung disease |
| 07/08/2004 | WO2004042361A3 Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 07/08/2004 | WO2004019979A3 Vaccine comprising il-13 and an adjuvant |
| 07/08/2004 | WO2004019975A3 Il-14 vaccine for the treatment of asthma and atopic disorders |
| 07/08/2004 | WO2004012653A3 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 07/08/2004 | WO2003105771A3 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/08/2004 | WO2003103663A3 Substituted pyrrolines as kinase inhibitors |
| 07/08/2004 | WO2003097598A8 Compound exhibiting pgd 2 receptor antagonism |
| 07/08/2004 | WO2003070918A3 Rna interference by modified short interfering nucleic acid |
| 07/08/2004 | WO2003070192A3 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 07/08/2004 | WO2003066822A3 Truncated aggrecanase molecules |
| 07/08/2004 | WO2003042358A3 Methods of using 48149, a human aminopeptidase family member |
| 07/08/2004 | WO2002097060A3 Carbohydrate-associated proteins |
| 07/08/2004 | US20040132984 Oligonuclelotide sequences for use in controlling expression and translation of neutrophil gelatinase associated lipocalin (NGAL) and treatment and prevention of inflammatory bowel disease: RNA interference; gene expression inhibition |
| 07/08/2004 | US20040132973 for gene therapy and vaccination; enzyme-linked immunosorbent assay (ELISA); kits; genetic engineering |
| 07/08/2004 | US20040132827 Phenylephrine tannate, pyrilamine tannate and dextromethorphan tannate salts in pharmaceutical compositions |
| 07/08/2004 | US20040132822 Crystalline solid form of (2S,5Z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 07/08/2004 | US20040132809 Cell adhesion inhibitors |
| 07/08/2004 | US20040132805 preferably also contains a compound that donates, transfers, releases or induces production of nitric oxide and a hydralazine antioxidant; for treating and/or preventing a vascular disease characterized by nitric oxide insufficiency |
| 07/08/2004 | US20040132804 1-aminoindane derivatives, e.g., 1-(cyclopentylcarbonylamino)-5-(4-cyclopropyl-2-(phenylsulfonyl)phenylsulfonyl)indane; exhibit anti-inflammatory and immunomodulatory activity |
| 07/08/2004 | US20040132781 Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2004 | US20040132774 Especially (2R)-N-(1-(6-aminopyridin-2-ylmethyl)1-methyl-piperdin-4-yl)-2-((1R)-3,3, -difluorocyclopentyl)-2-hydroxy-2-phenylacetamide iodide; treating asthma, chronic obstructive pulmonary disorder and allergic or infectious rhinitis |
| 07/08/2004 | US20040132768 substituted with (hetero)aryl carbonyloxy group and quaternized, e.g., 3(R)-Diphenylacetoxy-1-(3-phenoxy-propyl)-1-azoniabicyclo[2.2.2]octane; bromide; antimuscarinic agents for treating COPD, chronic bronchitis, asthma and rhinitis. |
| 07/08/2004 | US20040132748 Novel adenne derivatives |
| 07/08/2004 | US20040132744 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications. |